Mitochondrial dysfunction in white adipose tissue

Trends in Endocrinology and Metabolism

Volumn 23, Issue 9, 2012, Pages 435-443

  Kusminski, Christine M ^a   Scherer, Philipp E ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ADIPONECTIN; ALPHA TOCOPHEROL; ANTIDIABETIC AGENT; ANTIOXIDANT; ASCORBIC ACID; CARBONYL CYANIDE 4 (TRIFLUOROMETHOXY)PHENYLHYDRAZONE; FATTY ACID; GLUTATHIONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; ROSIGLITAZONE; THIOCTIC ACID; UBIDECARENONE;

ADIPOCYTE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOGENESIS; CALORIC RESTRICTION; CELL DIFFERENTIATION; ENERGY METABOLISM; ESTERIFICATION; EXERCISE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOGENESIS; LIPOLYSIS; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; SKELETAL MUSCLE; THERMOGENESIS; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ANIMALS; FATTY ACIDS; HUMANS; MITOCHONDRIA;

EID: 84865440201     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2012.06.004     Document Type: Article

References (89)

1. Spiegelman B.M., Flier J.S. Obesity and the regulation of energy balance. Cell 2001, 104:531-543.
2. Patti M.E., Corvera S. The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr. Rev. 2010, 31:364-395.
3. Keller M.P., Attie A.D. Physiological insights gained from gene expression analysis in obesity and diabetes. Annu. Rev. Nutr. 2010, 30:341-364.
4. Wang P., et al. The secretory function of adipocytes in the physiology of white adipose tissue. J. Cell Physiol. 2008, 216:3-13.
5. Sun K., et al. Adipose tissue remodeling and obesity. J. Clin. Invest. 2011, 121:2094-2101.
6. De Pauw A., et al. Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations. Am. J. Pathol. 2009, 175:927-939.
7. Tormos K.V., et al. Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab. 2011, 14:537-544.
8. Loh K., et al. Reactive oxygen species enhance insulin sensitivity. Cell Metab. 2009, 10:260-272.
9. Lu R.H., et al. Mitochondrial development and the influence of its dysfunction during rat adipocyte differentiation. Mol. Biol. Rep. 2010, 37:2173-2182.
10. Nye C., et al. Reassessing triglyceride synthesis in adipose tissue. Trends Endocrinol. Metab. 2008, 19:356-361.
11. Cadoudal T., et al. Pyruvate dehydrogenase kinase 4: regulation by thiazolidinediones and implication in glyceroneogenesis in adipose tissue. Diabetes 2008, 57:2272-2279.
12. Muoio D.M., Newgard C.B. Obesity-related derangements in metabolic regulation. Annu. Rev. Biochem. 2006, 75:367-401.
13. Brookheart R.T., et al. As a matter of fat. Cell Metab. 2009, 10:9-12.
14. Gao C.L., et al. Mitochondrial dysfunction is induced by high levels of glucose and free fatty acids in 3T3-L1 adipocytes. Mol. Cell. Endocrinol. 2010, 320:25-33.
15. Wilson-Fritch L., et al. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J. Clin. Invest. 2004, 114:1281-1289.
16. Asterholm I.W., et al. Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1. Cell Metab. 2012, 15:171-185.
17. Choo H.J., et al. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 2006, 49:784-791.
18. Devarakonda S., et al. Disorder-to-order transition underlies the structural basis for the assembly of a transcriptionally active PGC-1alpha/ERRgamma complex. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:18678-18683.
19. + system. Genes Dev. 2012, 26:259-270.
20. Bogacka I., et al. Structural and functional consequences of mitochondrial biogenesis in human adipocytes in vitro. J. Clin. Endocrinol. Metab. 2005, 90:6650-6656.
21. Mustelin L., et al. Acquired obesity and poor physical fitness impair expression of genes of mitochondrial oxidative phosphorylation in monozygotic twins discordant for obesity. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E148-E154.
22. Brand M.D. The sites and topology of mitochondrial superoxide production. Exp. Gerontol. 2010, 45:466-472.
23. Fisher-Wellman K.H., Neufer P.D. Linking mitochondrial bioenergetics to insulin resistance via redox biology. Trends Endocrinol. Metab. 2012, 23:142-153.
24. 2 in cells and thereby their biological state. Free Radic. Biol. Med. 2006, 41:1338-1350.
25. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J. Clin. Invest. 2009, 119:573-581.
26. Lee H.Y., et al. Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell Metab. 2010, 12:668-674.
27. Curtis J.M., et al. Downregulation of adipose glutathione S-transferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction. Diabetes 2010, 59:1132-1142.
28. Houstis N., et al. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
29. Wang T., et al. Respiration in adipocytes is inhibited by reactive oxygen species. Obesity (Silver Spring) 2010, 18:1493-1502.
30. Lin Y., et al. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J. Biol. Chem. 2005, 280:4617-4626.
31. Chen X.H., et al. TNF-alpha induces mitochondrial dysfunction in 3T3-L1 adipocytes. Mol. Cell. Endocrinol. 2010, 328:63-69.
32. Furukawa S., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004, 114:1752-1761.
33. De Pauw A., et al. Mild mitochondrial uncoupling does not affect mitochondrial biogenesis but downregulates pyruvate carboxylase in adipocytes: role for triglyceride content reduction. Am. J. Physiol. Endocrinol. Metab. 2012, 302:E1123-E1141.
34. Demozay D., et al. FALDH reverses the deleterious action of oxidative stress induced by lipid peroxidation product 4-hydroxynonenal on insulin signaling in 3T3-L1 adipocytes. Diabetes 2008, 57:1216-1226.
35. Goldstein B.J., et al. Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxid. Redox Signal. 2005, 7:1021-1031.
36. Carriere A., et al. Inhibition of preadipocyte proliferation by mitochondrial reactive oxygen species. FEBS Lett. 2003, 550:163-167.
37. MacLaren R., et al. Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue. J. Lipid Res. 2008, 49:308-323.
38. Wilson-Fritch L., et al. Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol. Cell. Biol. 2003, 23:1085-1094.
39. Rosen E.D., MacDougald O.A. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 2006, 7:885-896.
40. Kaji H., et al. Genetic variations at the CCAAT/enhancer-binding protein delta are associated with metabolic phenotypes in the Japanese population. Metab. Syndr. Relat. Disord. 2008, 6:24-31.
41. Kaaman M., et al. Strong association between mitochondrial DNA copy number and lipogenesis in human white adipose tissue. Diabetologia 2007, 50:2526-2533.
42. Shi X., et al. Paradoxical effect of mitochondrial respiratory chain impairment on insulin signaling and glucose transport in adipose cells. J. Biol. Chem. 2008, 283:30658-30667.
43. Rylova S.N., et al. Activity profiles of deoxynucleoside kinases and 5'-nucleotidases in cultured adipocytes and myoblastic cells: insights into mitochondrial toxicity of nucleoside analogs. Biochem. Pharmacol. 2005, 69:951-960.
44. Wang C.H., et al. Mitochondrial dysfunction in insulin insensitivity: implication of mitochondrial role in type 2 diabetes. Ann. N. Y. Acad. Sci. 2010, 1201:157-165.
45. Vankoningsloo S., et al. CREB activation induced by mitochondrial dysfunction triggers triglyceride accumulation in 3T3-L1 preadipocytes. J. Cell Sci. 2006, 119:1266-1282.
46. Owen O.E., et al. The key role of anaplerosis and cataplerosis for citric acid cycle function. J. Biol. Chem. 2002, 277:30409-30412.
47. Olswang Y., et al. A mutation in the peroxisome proliferator-activated receptor gamma-binding site in the gene for the cytosolic form of phosphoenolpyruvate carboxykinase reduces adipose tissue size and fat content in mice. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:625-630.
48. Ji C., et al. IL-6 induces lipolysis and mitochondrial dysfunction, but does not affect insulin-mediated glucose transport in 3T3-L1 adipocytes. J. Bioenerg. Biomembr. 2011, 43:367-375.
49. Cho S.Y., et al. Proteomic analysis of mitochondrial proteins of basal and lipolytically (isoproterenol and TNF-alpha)-stimulated adipocytes. J. Cell Biochem. 2009, 106:257-266.
50. Nawrocki A.R., et al. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J. Biol. Chem. 2006, 281:2654-2660.
51. Fridlyand L.E., Philipson L.H. Reactive species, cellular repair and risk factors in the onset of type 2 diabetes mellitus: review and hypothesis. Curr. Diabetes Rev. 2006, 2:241-259.
52. Voloboueva L.A., et al. (R)-alpha-lipoic acid protects retinal pigment epithelial cells from oxidative damage. Invest. Ophthalmol. Vis. Sci. 2005, 46:4302-4310.
53. Shen W., et al. R-alpha-lipoic acid and acetyl-L-carnitine complementarily promote mitochondrial biogenesis in murine 3T3-L1 adipocytes. Diabetologia 2008, 51:165-174.
54. Clapham J.C., Arch J.R. Targeting thermogenesis and related pathways in anti-obesity drug discovery. Pharmacol. Ther. 2011, 131:295-308.
55. Harper J.A., et al. Mitochondrial uncoupling as a target for drug development for the treatment of obesity. Obes. Rev. 2001, 2:255-265.
56. Hsiao A.L., et al. Pediatric fatality following ingestion of dinitrophenol: postmortem identification of a 'dietary supplement'. Clin. Toxicol. (Phila.) 2005, 43:281-285.
57. Tejerina S., et al. Mild mitochondrial uncoupling induces 3T3-L1 adipocyte de-differentiation by a PPARgamma-independent mechanism, whereas TNFalpha-induced de-differentiation is PPARgamma dependent. J. Cell Sci. 2009, 122:145-155.
58. Toledo F.G., et al. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes 2007, 56:2142-2147.
59. Bostrom P., et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012, 481:463-468.
60. Arany Z., et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 2008, 451:1008-1012.
61. Sun K., et al. Dichotomous effects of VEGF-A on adipose tissue dysfunction. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:5874-5879.
62. Brand M.D., Nicholls D.G. Assessing mitochondrial dysfunction in cells. Biochem. J. 2011, 435:297-312.
63. Rieusset J. Mitochondria and endoplasmic reticulum: mitochondria-endoplasmic reticulum interplay in type 2 diabetes pathophysiology. Int. J. Biochem. Cell Biol. 2011, 43:1257-1262.
64. Lim J.H., et al. Coupling mitochondrial dysfunction to endoplasmic reticulum stress response: a molecular mechanism leading to hepatic insulin resistance. Cell. Signal. 2009, 21:169-177.
65. Muoio D.M., Koves T.R. Lipid-induced metabolic dysfunction in skeletal muscle. Novartis Found. Symp. 2007, 286:24-38.
66. Koves T.R., et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 2008, 7:45-56.
67. Holland W.L., et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat. Med. 2011, 17:55-63.
68. Bikman B.T., Summers S.A. Ceramides as modulators of cellular and whole-body metabolism. J. Clin. Invest. 2011, 121:4222-4230.
69. Deng Y., Scherer P.E. Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann. N. Y. Acad. Sci. 2010, 1212:E1-E19.
70. Scherer P.E., et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 1995, 270:26746-26749.
71. Asterholm I.W., Scherer P.E. Enhanced metabolic flexibility associated with elevated adiponectin levels. Am. J. Pathol. 2010, 176:1364-1376.
72. Kusminski C.M., Scherer P.E. The road from discovery to clinic: adiponectin as a biomarker of metabolic status. Clin. Pharmacol. Ther. 2009, 86:592-595.
73. Halberg N., et al. Systemic fate of the adipocyte-derived factor adiponectin. Diabetes 2009, 58:1961-1970.
74. Wang Z.V., et al. Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention. Mol. Cell. Biol. 2007, 27:3716-3731.
75. Koh E.H., et al. Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 2007, 56:2973-2981.
76. Koh E.H., et al. eNOS plays a major role in adiponectin synthesis in adipocytes. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E846-E853.
77. Kim J.Y., et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 2007, 117:2621-2637.
78. Chevillotte E., et al. Uncoupling protein-2 controls adiponectin gene expression in adipose tissue through the modulation of reactive oxygen species production. Diabetes 2007, 56:1042-1050.
79. 2+ and AMPK/SIRT1. Nature 2010, 464:1313-1319.
80. Zhou M., et al. Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury. Hepatology 2008, 48:1087-1096.
81. Feldmann H.M., et al. UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab. 2009, 9:203-209.
82. Cypess A.M., et al. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 2009, 360:1509-1517.
83. Fruhbeck G., et al. BAT: a new target for human obesity?. Trends Pharmacol. Sci. 2009, 30:387-396.
84. van Marken Lichtenbelt W.D., et al. Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 2009, 360:1500-1508.
85. Jager S., et al. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:12017-12022.
86. Duncan J.G., et al. Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway. Circulation 2007, 115:909-917.
87. Seale P., et al. Transcriptional control of brown fat determination by PRDM16. Cell Metab. 2007, 6:38-54.
88. Kajimura S., et al. Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex. Genes Dev. 2008, 22:1397-1409.
89. Ohno H., et al. PPARgamma agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab. 2012, 15:395-404.